News

Will Baxter's Q3 Earnings Show Progress Despite Cost Pressures?

BAX's Q3 revenues may rise, but earnings may fall amid tariffs, manufacturing costs and infusion pump challenges. Will stronger demand offset pressures?

Yahoo·10:23BAX▼−1.0%

1 S&P 500 stock with exciting potential and 2 facing challenges

While the S&P 500 (^GSPC) includes industry leaders, not every stock in the index is a winner. Some companies are past their prime, weighed down by poor execution, weak financials, or structural headwinds.

Yahoo·16:08

Analysts Estimate Baxter International (BAX) to Report a Decline in Earnings: What to Look Out for

Baxter (BAX) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Yahoo·09:00BAX▼−1.0%

Why Baxter (BAX) Stock Is Down Today

Shares of healthcare company Baxter International (NYSE:BAX) fell 3.8% in the afternoon session after the U.S. Food and Drug Administration publicly posted a warning letter citing significant manufacturing and contamination-control violations at its primary Round Lake, Illinois drug facility.

Yahoo·16:21BAX▼−1.0%

S&P 500 Unusual Volume Movers for October 20

Ten S&P 500 stocks traded above their 50-day average volume on October 20, with gains in MSCI, Hasbro, Northrop, Hilton, 3M and Equifax and declines in GE, GM, DaVita and Baxter.

ChartMill·13:05BAX▼−1.0%

Firing on All Cylinders: Baxter (NYSE:BAX) Q2 Earnings Lead the Way

As the Q2 earnings season comes to a close, it’s time to take stock of this quarter’s best and worst performers in the medical devices & supplies - diversified industry, including Baxter (NYSE:BAX) and its peers.

Yahoo·11:44BAX▼−1.0%

Baxter’s Quarterly Earnings Preview: What You Need to Know

Baxter International is gearing up to report its third-quarter results later this month, and analysts anticipate a sharp double-digit year-over-year drop in earnings.

Yahoo·06:20BAX▼−1.0%

Baxter International: The Vantive Transition Complicates Margin Recovery

Baxter (BAX) rated Hold with a $25 target and 2.6% upside. BAX trades at a discount to the sector. See here for a detailed investment analysis.

SeekingAlpha·03:10BAX▼−1.0%

Baxter (BAX) Stock May Be 30% Undervalued On Cash Flow

Baxter International has delivered a 24.9% gain year to date despite its share price sitting near US$24. That mix of recent strength and long term weakness puts the focus squarely on what the company’s cash flows are really worth today. With a Discounted Cash Flow (DCF) estimate available, the key issue is how the market’s current price lines up with the cash that Baxter International is expected to generate over time. The stock has fallen 66.3% over the past 5 years, which makes the current...

Yahoo·18:08BAX▼−1.0%

Barclays Initiates Coverage of Baxter International at Underweight

Fintel·18:07BAX▼−1.0%

Baxter to Host Third-Quarter 2026 Financial Results Conference Call for Investors

DEERFIELD, Ill., October 07, 2026--Baxter International Inc. (NYSE:BAX), a global medtech leader, will host a conference call to discuss its third-quarter 2026 financial results on Thursday, October 29, 2026, at 7:30 a.m. Central Time. To participate in this conference call please follow this link https://events.q4inc.com/analyst/129835310?pwd=2FG2j7ZZ to pre-register for the call and receive the call information.

Yahoo·16:15BAX▼−1.0%

Are Investors Undervaluing Baxter International (BAX) Right Now?

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.

Yahoo·08:40BAX▼−1.0%

Is Baxter International (BAX) Stock Outpacing Its Medical Peers This Year?

Here is how Baxter International (BAX) and Bayer Aktiengesellschaft (BAYRY) have performed compared to their sector so far this year.

Yahoo·08:40BAX▼−1.0%

3 of Wall Street’s Favorite Stocks with Warning Signs

The stocks in this article have caught Wall Street’s attention in a big way, with price targets implying returns above 20%. But investors should take these forecasts with a grain of salt because analysts typically say nice things about companies so their firms can win business in other product lines like M&A advisory.

Yahoo·04:45

What Investors Might Be Missing On Baxter International (BAX)

Baxter International (BAX) has drawn fresh attention after publishing its 2026 Connected Hospital Report, spotlighting how U.S. hospitals are using technology maturity benchmarks to pursue operational efficiency, workflow automation, and data integration priorities. Baxter International’s recent Connected Hospital Report lands after a mixed run in the stock, with the share price up 20.41% year to date and 8.25% over 90 days but down 10.14% over the past month. Total shareholder return sits at...

Yahoo·15:12BAX▼−1.0%

Baxter Releases Inaugural Connected Hospital Report

DEERFIELD, Ill., September 30, 2026--Baxter International Inc. (NYSE:BAX), a global medtech leader, today announced the release of its 2026 Connected Hospital Report, offering new insights into how hospitals across the United States are leveraging technology investments to drive clinical and operational outcomes.

Yahoo·09:00

Here's Why You Should Retain Baxter Stock in Your Portfolio for Now

BAX's portfolio reset and growth in connected care and advanced surgery support prospects, but margins, Novum IQ and China pricing remain risks.

Yahoo·09:42BAX▼−1.0%

2 Volatile Stocks for Long-Term Investors and 1 Facing Challenges

A highly volatile stock can deliver big gains - or just as easily wipe out a portfolio if things go south. While some investors embrace risk, mistakes can be costly for those who aren’t prepared.

Yahoo·07:04

These S&P500 stocks are moving in today's session

Get insights into the S&P500 index performance on Tuesday. Explore the top gainers and losers within the S&P500 index in today's session.

ChartMill·12:35

Is Baxter Stock Underperforming the Nasdaq?

Baxter International has underperformed the Nasdaq over the past year, and analysts are cautious about the stock’s prospects.

Yahoo·10:32BAX▼−1.0%

Baxter International Inc. (BAX) Presents at Wells Fargo 21st Annual Healthcare Conference Transcript

Baxter International Inc. (BAX) Wells Fargo 21st Annual Healthcare Conference September 9, 2026 12:45 PM EDTCompany ParticipantsAndrew Hider - CEO,...

SeekingAlpha·11:37BAX▼−1.0%

Reported Earlier, Medline Prices Secondary Offering Of 75M Class A Shares At $41.00/Share By Blackstone, Carlyle, Hellman & Friedman And ADIA Affiliates

Benzinga·08:05

BAX Raises 2026 Outlook as Strong Q2 Growth Offsets Margin Pressure

Baxter raises its 2026 sales and earnings outlook after strong Q2 growth, though manufacturing costs, tariffs and pricing pressure margins.

Yahoo·15:38BAX▼−1.0%

Drug Reconstitution Systems Market Trends, Shares and Growth Opportunities Worldwide 2026-2035 Featuring Profiles of Baxter, ICU Medical, B. Braun, Vetter Pharma, Nipro, SCHOTT-KAISHA

Dublin, Sept. 07, 2026 (GLOBE NEWSWIRE) -- The "Drug Reconstitution Systems Market - Trends and Forecast Till 2035" has been added to ResearchAndMarkets.com's offering. The global drug reconstitution systems market is projected to increase from approximately USD 5.9 billion in 2026 to USD 10.8 billion by 2035, representing a compound annual growth rate (CAGR) of about 7.0% during the forecast period. Market expansion is being supported by the growing pipeline of biologics, biosimilars, vaccines,

Yahoo·06:57BAX

3 Healthcare Stocks We Keep Off Our Radar

Healthcare companies are pushing the status quo by innovating in areas like drug development and digital health. Those leading the charge have not only realized strong financial performance but also propelled the broader industry’s returns as healthcare stocks have gained 22.1% over the past six months while the S&P 500 was up 12.1%.

Yahoo·10:22

Everything I Learned from My Hot Chart Summer, and How My 21 Stocks Picks Have Performed.

Great stock picks are just the start to building a portfolio that can shelter you through whatever the market brings.

Yahoo·10:30

Will New Capital Markets And Chip Leaders On The Board Change IonQ's (IONQ) Narrative

In recent days, IonQ appointed two new board members, veteran finance executive Dr. Eric Ball and former SkyWater chairman and Samsung North America CEO Timothy Baxter, adding deep capital markets and semiconductor leadership experience to its governance. The combination of Ball’s large-scale financing and M&A track record with Baxter’s chip industry and go-to-market expertise could be important as IonQ integrates SkyWater and scales its merchant quantum supply ambitions. Next, we’ll...

Yahoo·15:19BAX▼−1.0%